Optimizing Sequencing Strategies in R/R Follicular Lymphoma

Loretta J. Nastoupil, MD, and Amitkumar Mehta, MD, discuss treatment selection in relapsed/refractory follicular lymphoma.

Loretta J. Nastoupil, MD, and Amitkumar Mehta, MD, discuss methods of building on the lenalidomide/rituximab backbone in relpased/refractory follicular lymphoma.

Loretta J. Nastoupil, MD, and Amitkumar Mehta, MD, discuss data for tafasitamab- and epcoritamab-based combinations in relapsed/refractory follicular lymphoma.

Loretta J. Nastoupil, MD, and Amitkumar Mehta, MD, discuss factors that can inform sequencing planning in follicular lymphoma management.

Loretta J. Nastoupil, MD, and Amitkumar Mehta, MD, discuss the role of targeted therapies and rechallenging with certain classes of agents in follicular lymphoma.

Loretta J. Nastoupil, MD, and Amitkumar Mehta, MD, discuss future research to watch in follicular lymphoma.